Skip to content
Disclosery

EXANE DERIVATIVES: RACE position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on RACE, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 1,983 RACE shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 1,983 shares
    Change vs previous 13F -742 shares

    0.21% of the 13F portfolio, value $360,242.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 2,725 shares
    Change vs previous 13F -85,450 shares

    0.17% of the 13F portfolio, value $601,042.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 88,175 shares
    Change vs previous 13F +86,977 shares

    5.53% of the 13F portfolio, value $22,719,777.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 1,198 shares
    Change vs previous 13F -24,051 shares

    0.06% of the 13F portfolio, value $251,024.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 25,249 shares
    Change vs previous 13F not available

    1.25% of the 13F portfolio, value $5,318,539.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).